论文信息 - Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern - 字舞流文

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern

Wenhong Zhang | Qiran Zhang | Hongyu Wang | Yi Zhang | Yang Zhou | Ke Lin | Yuanhan Zhao | C. Qiu | Jieyu Song | Jingwen Ai | Zhangfan Fu | Mingxiang Fan | Haocheng Zhang

[1] X. Guo,et al. Heterologous prime-boost immunization with CoronaVac and Convidecia , 2021, medRxiv.

[2] K. Chu,et al. Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial , 2021, medRxiv.

[3] Yu Li,et al. SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients , 2021, Cellular & Molecular Immunology.

[4] A. Pan,et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial , 2021, EClinicalMedicine.

[5] J. Vekemans,et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection , 2021, Nature Medicine.

[6] J. Nie,et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 , 2020, Emerging microbes & infections.